[1] [1] Simental-Menda LE, Rodrguez-Morn M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J]. Metab Syndr Relat Disord, 2008, 6(4): 299-304.

[2] [2] Liu L, Luo Y, Liu M, et al. Triglyceride glucose-related indexes and lipid accumulation products-reliable markers of insulin resistance in the Chinese population[J]. Front Nutr, 2024, 11: 1373039.

[3] [3] Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease[J]. Metabolism, 2021, 119: 154766.

[4] [4] da Silva AA, do Carmo JM, Li X, et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited[J]. Can J Cardiol, 2020, 36(5): 671-682.

[5] [5] Raimi TH, Dele-Ojo BF, Dada SA, et al. Triglyceride-glucose index and related parameters predicted metabolic syndrome in nigerians[J]. Metab Syndr Relat Disord, 2021, 19(2): 76-82.

[6] [6] Qiao Y, Wang Y, Chen C, et al. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank[J]. Cardiovasc Diabetol, 2025, 24(1): 12.

[7] [7] Pinto-Junior DC, Silva KS, Michalani ML, et al. Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression[J]. Sci Rep, 2018, 8: 8109.

[8] [8] Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese[J]. Biomed Pharmacother, 2021, 137: 111315.

[9] [9] Tajeu GS, Booth JN 3rd, Colantonio LD, et al. Incident cardiovascular disease among adults with blood pressure < 140/90 mmHg[J]. Circulation, 2017, 136(9): 798-812.

[10] [10] Liu H, Meng C, Wang Z, et al. Association of novel insulin resistance indices with blood pressure in new-onset hypertension and elevated blood pressure individuals: a cross-sectional study[J]. Diabetes Metab Syndr Obes, 2023, 16: 3953-3965.

[11] [11] Yang C, Song Y, Wang X, et al. Association of hypertension with the triglyceride-glucose index and its associated indices in the Chinese population: a 6-year prospective cohort study[J]. J Clin Hypertens (Greenwich), 2024, 26(1): 53-62.

[12] [12] Li Y, Gui J, Zhang X, et al. Predicting hypertension by obesity-and lipid-related indices in mid-aged and elderly Chinese: a nationwide cohort study from the China Health and Retirement Longitudinal Study[J]. BMC Cardiovasc Disord, 2023, 23(1): 201.

[13] [13] Liang X, Huang Y, Han X. Associations between coronary heart disease and risk of cognitive impairment: a meta-analysis[J]. Brain Behav, 2021, 11(5): e02108.

[14] [14] Cui C, Qi Y, Song J, et al. Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults[J]. Cardiovasc Diabetol, 2024, 23(1): 185.

[15] [15] Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018[J]. Cardiovasc Diabetol, 2024, 23(1): 8.

[16] [16] Liu L, Peng J, Wang N, et al. Comparison of seven surrogate insulin resistance indexes for prediction of incident coronary heart disease risk: a 10-year prospective cohort study[J]. Front Endocrinol (Lausanne), 2024, 15: 1290226.

[17] [17] Lopaschuk GD, Karwi QG, Tian R, et al. Cardiac energy metabolism in heart failure[J]. Circ Res, 2021, 128(10): 1487-1513.

[18] [18] Yang S, Shi X, Liu W, et al. Association between triglyceride glucose-body mass index and heart failure in subjects with diabetes mellitus or prediabetes mellitus: a cross-sectional study[J]. Front Endocrinol (Lausanne), 2023, 14: 1294909.

[19] [19] Jia Y, Zhang Y, Bai S, et al. Triglyceride glucose index is a risk factor for heart failure: a prospective cohort study[J]. ESC Heart Fail, 2024, 11(6): 3833-3841.

[20] [20] Dou J, Guo C, Wang Y, et al. Association between triglyceride glucose-body mass and one-year all-cause mortality of patients with heart failure: a retrospective study utilizing the MIMIC-Ⅳdatabase[J]. Cardiovasc Diabetol, 2023, 22(1): 309.

[21] [21] Lyu L, Wang X, Xu J, et al. Association between triglyceride glucose-body mass index and long-term adverse outcomes of heart failure patients with coronary heart disease[J]. Cardiovasc Diabetol, 2024, 23(1): 162.

[22] [22] Lavie CJ, Kokkinos P, Lin GM. Obesity paradox is still alive in heart failure[J]. Heart, 2023, 109(20): 1506-1507.

[23] [23] Alebna PL, Mehta A, Yehya A, et al. Update on obesity, the obesity paradox, and obesity management in heart failure[J]. Prog Cardiovasc Dis, 2024, 82: 34-42.

[24] [24] Parto P, Lavie CJ, Arena R, et al. Body habitus in heart failure: understanding the mechanisms and clinical significance of the obesity paradox[J]. Future Cardiol, 2016, 12(6): 639-653.

[25] [25] Peterson LR. Obesity and insulin resistance: effects on cardiac structure, function, and substrate metabolism[J]. Curr Hypertens Rep, 2006, 8(6): 451-456.

[26] [26] Brundel BJJM, Ai X, Hills MT, et al. Atrial fibrillation[J]. Nat Rev Dis Primers, 2022, 8(1): 21.

[27] [27] Liu X, Abudukeremu A, Jiang Y, et al. U-shaped association between the triglyceride-glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease[J]. Cardiovasc Diabetol, 2023, 22(1): 118.

[28] [28] Yan Q, Liang JQ, Yuan YD, et al. Association between the cumulative triglyceride-glucose index and the recurrence of atrial fibrillation after radiofrequency catheter ablation[J]. J Geriatr Cardiol, 2024, 21(2): 200-210.

[29] [29] Hu Y, Zhao Y, Zhang J, et al. The association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study from MIMIC-Ⅳ database[J]. Cardiovasc Diabetol, 2024, 23(1): 64.

[30] [30] Lee SH, Chen YC, Chen YJ, et al. Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes[J]. Life Sci, 2007, 80(19): 1806-1815.

[31] [31] Duran Karaduman B, Ayhan H, Kele T, et al. The triglyceride-glucose index predicts peripheral artery disease complexity[J]. Turk J Med Sci, 2020, 50(5): 1217-1222.

[32] [32] Miao Y, Wang Y, Wang Y, et al. The association between triglyceride-glucose index and its combination with obesity indicators and lower extremity peripheral artery disease in patients with type 2 diabetes mellitus: a cross-sectional study[J]. Diabetes Metab Syndr Obes, 2024, 17: 2607-2617.